We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT icon
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 28.03%
2 Consumer Discretionary 15.41%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SM icon
176
SM Energy
SM
$9.4B
$3.65M 0.09%
43,410
+2,375
+6% +$182K
2013 Q2
4 quarters
HUBG icon
177
HUB Group
HUBG
$1.62B
$3.65M 0.09%
144,700
-32,640
-18% -$744K
2013 Q2
4 quarters
INVX icon
178
Innovex International
INVX
$1.96B
$3.64M 0.09%
33,315
-50
-0.1% -$5.37K
2013 Q2
4 quarters
THS icon
179
DELISTED
Treehouse Foods
THS
$3.64M 0.09%
45,435
+85
+0.2% +$6.33K
2013 Q2
4 quarters
MORN icon
180
Morningstar
MORN
$7.78B
$3.62M 0.09%
50,430
+70
+0.1% +$5.12K
2013 Q2
4 quarters
STI icon
181
DELISTED
SunTrust Banks, Inc.
STI
$3.61M 0.09%
90,075
+5,000
+6% +$195K
2014 Q1
1 quarter
UNFI icon
182
United Natural Foods
UNFI
$2.88B
$3.59M 0.09%
55,175
-65
-0.1% -$4.35K
2013 Q2
4 quarters
MMSI icon
183
Merit Medical Systems
MMSI
$5.33B
$3.58M 0.09%
237,405
-195
-0.1% -$2.7K
2013 Q2
4 quarters
WWD icon
184
Woodward
WWD
$19.4B
$3.57M 0.08%
70,958
+135
+0.2% +$6.15K
2013 Q2
4 quarters
BRO icon
185
Brown & Brown
BRO
$23.2B
$3.56M 0.08%
232,170
-22,290
-9% -$335K
2013 Q2
4 quarters
SP icon
186
DELISTED
SP Plus Corporation
SP
$3.56M 0.08%
166,655
-585
-0.3% -$13.6K
2013 Q2
4 quarters
ATW
187
DELISTED
Atwood Oceanics
ATW
$3.56M 0.08%
67,835
-215
-0.3% -$10.6K
2013 Q2
4 quarters
ALC icon
188
DELISTED
ASSISTED LIVING CONCEPTS INC NEW CL A COM STK (NV)
ALC
$3.55M 0.08%
71,650
-95
-0.1% -$4.71K
2013 Q2
4 quarters
MNRO icon
189
Monro
MNRO
$426M
$3.49M 0.08%
65,655
+5
+0% +$274
2013 Q2
4 quarters
HTWR
190
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$3.48M 0.08%
39,370
-5
-0% -$448
2013 Q2
4 quarters
ASNA
191
DELISTED
Ascena Retail Group, Inc.
ASNA
$3.46M 0.08%
10,108
+2,487
+33% +$850K
2013 Q2
4 quarters
LZB icon
192
La-Z-Boy
LZB
$1.2B
$3.39M 0.08%
146,310
+10
+0% +$247
2013 Q2
4 quarters
PIR
193
DELISTED
Pier 1 Imports, Inc.
PIR
$3.35M 0.08%
10,860
+1,540
+17% +$541K
2013 Q2
4 quarters
RBC icon
194
RBC Bearings
RBC
$15.8B
$3.23M 0.08%
50,510
+135
+0.3% +$8.37K
2013 Q2
4 quarters
BECN icon
195
DELISTED
Beacon Roofing Supply, Inc.
BECN
$3.17M 0.08%
95,890
-75
-0.1% -$2.64K
2013 Q2
4 quarters
INWK
196
DELISTED
InnerWorkings, Inc.
INWK
$3.13M 0.07%
368,855
-450
-0.1% -$3.36K
2013 Q2
4 quarters
MWIV
197
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$3.08M 0.07%
21,710
+40
+0.2% +$5.87K
2013 Q2
4 quarters
TRNX
198
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.07M 0.07%
131,465
-175
-0.1% -$3.64K
2013 Q2
4 quarters
FDS icon
199
Factset
FDS
$10.7B
$3.04M 0.07%
25,240
-5
-0% -$543
2013 Q2
4 quarters
GK icon
200
DELISTED
G&K Services Inc
GK
$2.89M 0.07%
+55,535
New +$3.02M
2014 Q2
0 quarters

Similar funds

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.